Showing results (11-20 of 247) with videos related to
Sort By:
Pageof 25
Advanced Drug Delivery Reviews|February 16, 2016
Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatmentsMechthild Krause, Anna Dubrovska, Annett Linge, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase InhibitorsGeoff S Higgins, Mechthild Krause, W Gillies McKenna, et al.International Journal of Radiation Biology|April 22, 2009
Cancer stem cells and radiotherapyMichael Baumann, Mechthild Krause, Howard Thames, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Cancer stem cells: targets and potential biomarkers for radiotherapyMechthild Krause, Ala Yaromina, Wolfgang Eicheler, et al.Zeitschrift Fur Medizinische Physik|August 16, 2014
Pre-clinical research in small animals using radiotherapy technology--a bidirectional translational approachFalk Tillner, Prasad Thute, Rebecca Bütof, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 20, 2005
Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude miceWolfgang Eicheler, Mechthild Krause, Franziska Hessel, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2019
Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AXTreewut Rassamegevanon, Steffen Löck, Michael Baumann, et al.Clinical and Translational Radiation Oncology|April 17, 2018
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer <i>in vitro</i> and <i>in vivo</i>Steffi Liebscher, Lydia Koi, Steffen Löck, et al.Nature Communications|November 15, 2017
Development of a genetic sensor that eliminates p53 deficient cellsJovan Mircetic, Antje Dietrich, Maciej Paszkowski-Rogacz, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
Preclinical evaluation of molecular-targeted anticancer agents for radiotherapyMechthild Krause, Daniel Zips, Howard D Thames, et al.Pageof 25